Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Sarcoma 1Ovarian Neoplasms 1Neurofibromatosis 2 1Neoplasm Metastasis 1Mesothelioma, Malignant 1Hemangiosarcoma 1Colorectal Neoplasms 1Cholangiocarcinoma 1Carcinoma, Ovarian Epithelial 1

Interventions

Everolimus 3Bevacizumab 3Lapatinib 2vistusertib 1icotinib 1Vascular Endothelial Growth Factor A 1Sunitinib 1Sirolimus 1Magnetic Resonance Imaging 1Exome 1Endostatins 1Crizotinib 1Axitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Neurofibromatosis 2 × Vascular Endothelial Growth Factor A × Clear all
NCT01767792 2021-02-12

Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas

University of Alabama at Birmingham

Phase 2 Completed
22 enrolled 14 charts
CNS

Neurofibromatosis 2

Data powered by HemOnc (CC BY 4.0) Colophon âš¡